Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

Nature. 1994 Apr 21;368(6473):756-60. doi: 10.1038/368756a0.


The 37-amino-acid polypeptide amylin is the principal constituent of the amyloid deposits that form in the islets of Langerhans in patients with type-2 diabetes mellitus, but its role in the pathogenesis of this disease is unresolved. In view of the fact that the beta-amyloid protein that forms fibrils in Alzheimer's disease is toxic to neurons, we have investigated whether amylin fibrils could be toxic to pancreatic islet cells. We show here that human amylin is toxic to insulin-producing beta-cells of the adult pancreas of rats and humans. This toxicity is mediated by the fibrillar form of the amylin peptide and requires direct contact of the fibrils with the cell surface. The mechanism of cell death involves RNA and protein synthesis and is characterized by plasma membrane blebbing, chromatin condensation and DNA fragmentation, indicating that amylin induces islet cell apoptosis. These findings indicate that amylin fibril formation in the pancreas may cause islet cell dysfunction and death in type-2 diabetes mellitus.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Amyloid / toxicity*
  • Amyloid beta-Peptides / pharmacology
  • Analysis of Variance
  • Animals
  • Apoptosis
  • Cats
  • Cell Line
  • Cells, Cultured
  • Diabetes Mellitus, Type 2 / etiology*
  • Diabetes Mellitus, Type 2 / pathology
  • Female
  • Humans
  • Islet Amyloid Polypeptide
  • Langerhans Cells / drug effects
  • Langerhans Cells / ultrastructure*
  • Male
  • Microscopy, Fluorescence
  • PC12 Cells
  • Peptide Fragments / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Species Specificity


  • Amyloid
  • Amyloid beta-Peptides
  • Islet Amyloid Polypeptide
  • Peptide Fragments
  • amyloid beta-protein (25-35)